Is the Appen (ASX:APX) share price a cheap buy?

Could the Appen Ltd (ASX:APX) share price be a really cheap buy now? It has actually fallen by 55% over the last six months.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Is the Appen Ltd (ASX:APX) share price a cheap buying opportunity?

Its shares have dropped 55% over the last six months and it's actually down by 62% since the high in August 2020.

Sometimes an ASX share can look good value after falling so hard, whereas other times it's still not cheap. Even after a huge decline, a business can still fall a long way.

appen share price

Image source: Getty Images

What happened to the Appen share price?

The ASX tech share, which provides datasets for machine learning and artificial intelligence, reported its FY20 result a few weeks ago for the year to 31 December 2020.

Appen said that revenue went up by 12% to $599.9 million. Underlying earnings before interest, tax, depreciation and amortisation (EBITDA) rose 8% to $108.6 million, whilst statutory EBITDA grew 23%.

Whilst statutory net profit after tax grew 23% to $50.5 million, underlying net profit after tax only rose 1% to $64.4 million. That growth wasn't as much as investors were expecting that it would be during the year, hence why the Appen share price fell as it updated investors about its expectations throughout the year.

There were some positives that Appen highlighted. It said its customer base is growing with 136 new customer wins in 2020, whilst there was a 34% increase in the number of projects with its top five customers. Appen also said that China revenue was growing by 60% quarter on quarter.

Appen's two divisions reported mixed results. Relevance revenue increased by 15% to $538.2 million, whilst speech and image revenue dropped by 10% to $61.2 million.

How did Appen explain the challenges?

Management explained that its sales process was impacted by the pandemic-driven shift to working from home, resulting in fewer customer wins in the second quarter and third quarter, before bouncing back in the fourth quarter.  

Appen also said that the pandemic reduced online advertising in the mid-2020s, impacting major customers and resulting in less spending on advertising-related AI programs as resources were re-prioritised to new products and some projects were deferred.

The company said it's involved in many of these new projects, which are in their early stages and growing, and will complement its major programs. A majority of deferred projects are recommencing in 2021.

Outlook for FY21

Appen said that at February 2021, its year to date revenue plus orders in hand for delivery in FY21 was approximately $240 million.

It's expecting FY21 underlying EBITDA to be in the range of $120 million to $130 million at constant currency rates, representing growth of 18% to 28%.

Broker ratings on the Appen share price

There are very different opinions about the Appen share price.

Ord Minnett rates Appen shares as a buy, with a price target of $24.75 – that suggests upside of around 50% over the next year. The broker thinks that Appen's long-term growth can continue and its valuation isn't expensive.

Using Ord Minnett's numbers, the Appen share price is valued at 29x FY21's estimated earnings and 22x FY22's estimated earnings.

Macquarie Group Ltd (ASX: MQG) has put a price target on Appen of $16 and the broker believes that there's going to be more competition for Appen as time goes on, hurting margins.

Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Appen Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Cheap Shares

Warren Buffett
Cheap Shares

I'm following Warren Buffett to snap up these cheap ASX stocks

These quality shares have been hammered. That's exactly why they're catching my eye.

Read more »

a woman with lots of shopping bags looks upwards towards the sky as if she is pondering something.
Cheap Shares

Is now the time to load up on CSL shares?

This could be a rare chance to buy a top biotech stock cheap.

Read more »

Couple looking at their phone surprised, symbolising a bargain buy.
Cheap Shares

Down 35% in 2026, are Xero shares the bargain buy of April?

Brokers think the tech stock could be primed for a strong rebound.

Read more »

Green tipped arrows in bullseye with green dollar sign
Cheap Shares

If I could buy just one ASX stock in April, it'd be Pro Medicus shares

This stock has been smashed, but the long-term story remains intact.

Read more »

A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
Cheap Shares

Are '50% off' CSL shares a once-in-a-decade opportunity?

This biotech giant's shares have lost half of their value. Let's see if now is the time to snap them…

Read more »

A young man talks tech on his phone while looking at a laptop with a financial graph superimposed across the image.
Cheap Shares

3 ASX shares to buy before the next market rally

These shares appear well-placed to rebound with the market when sentiment shifts.

Read more »

Three women athletes lie flat on a running track as though they have had a long hard race where they have fought hard but lost the event.
Cheap Shares

3 ASX shares down 25% (or more) to buy right now

Today’s sell-off could be a big buying opportunity if sentiment flips.

Read more »

An older man wearing glasses and a pink shirt sits back on his lounge with his hands behind his head and blowing air out of his cheeks.
Cheap Shares

3 ASX 200 shares down at least 30% to buy now

These ASX shares have fallen sharply, but their long-term outlook may still be intact.

Read more »